Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Exchange Rate Effect: 2023-2025

Historic Exchange Rate Effect for Gyre Therapeutics (GYRE) over the last 3 years, with Sep 2025 value amounting to $117,000.

  • Gyre Therapeutics' Exchange Rate Effect rose 10.38% to $117,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$39,000, marking a year-over-year decrease of 118.31%. This contributed to the annual value of -$273,000 for FY2024, which is 8.39% up from last year.
  • Per Gyre Therapeutics' latest filing, its Exchange Rate Effect stood at $117,000 for Q3 2025, which was up 138.78% from $49,000 recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Exchange Rate Effect ranged from a high of $231,000 in Q4 2023 and a low of -$900,000 during Q2 2023.
  • Over the past 3 years, Gyre Therapeutics' median Exchange Rate Effect value was $50,000 (recorded in 2025), while the average stood at -$32,273.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first slumped by 210.39% in 2024, then skyrocketed by 208.70% in 2025.
  • Gyre Therapeutics' Exchange Rate Effect (Quarterly) stood at $231,000 in 2023, then plummeted by 210.39% to -$255,000 in 2024, then increased by 10.38% to $117,000 in 2025.
  • Its last three reported values are $117,000 in Q3 2025, $49,000 for Q2 2025, and $50,000 during Q1 2025.